Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 7 studies | 23% ± 6% | |
| goblet cell | 7 studies | 39% ± 23% | |
| basal cell | 4 studies | 19% ± 5% | |
| respiratory goblet cell | 3 studies | 21% ± 1% | |
| squamous epithelial cell | 3 studies | 45% ± 20% | |
| secretory cell | 3 studies | 24% ± 4% |
Insufficient scRNA-seq data for expression of GALNT5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 99% | 978.43 | 573 / 578 | 81% | 11.86 | 938 / 1155 |
| stomach | 70% | 474.34 | 251 / 359 | 87% | 14.98 | 248 / 286 |
| intestine | 48% | 584.09 | 463 / 966 | 94% | 19.61 | 498 / 527 |
| esophagus | 39% | 467.10 | 565 / 1445 | 77% | 12.74 | 140 / 183 |
| breast | 40% | 87.03 | 183 / 459 | 70% | 10.85 | 781 / 1118 |
| prostate | 75% | 207.94 | 183 / 245 | 23% | 0.73 | 114 / 502 |
| bladder | 33% | 104.00 | 7 / 21 | 57% | 8.18 | 289 / 504 |
| pancreas | 1% | 1.85 | 4 / 328 | 88% | 22.04 | 156 / 178 |
| blood vessel | 77% | 339.50 | 1027 / 1335 | 0% | 0 | 0 / 0 |
| skin | 41% | 911.81 | 740 / 1809 | 28% | 3.08 | 134 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 9.41 | 31 / 45 |
| uterus | 2% | 13.36 | 3 / 170 | 43% | 4.88 | 198 / 459 |
| kidney | 6% | 8.29 | 5 / 89 | 35% | 3.38 | 317 / 901 |
| brain | 17% | 146.35 | 461 / 2642 | 10% | 0.65 | 73 / 705 |
| ovary | 6% | 10.94 | 11 / 180 | 20% | 0.84 | 88 / 430 |
| thymus | 1% | 1.07 | 4 / 653 | 23% | 1.37 | 138 / 605 |
| heart | 23% | 44.30 | 201 / 861 | 0% | 0 | 0 / 0 |
| adipose | 6% | 15.32 | 69 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 2.01 | 2 / 258 | 3% | 0.19 | 6 / 230 |
| spleen | 3% | 4.38 | 7 / 241 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 3% | 0.44 | 11 / 406 |
| peripheral blood | 2% | 5.47 | 21 / 929 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.58 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016266 | Biological process | O-glycan processing |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | GALNT5 |
| Protein name | Polypeptide N-acetylgalactosaminyltransferase 5 (EC 2.4.1.41) (Polypeptide GalNAc transferase 5) (GalNAc-T5) (pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5) Polypeptide N-acetylgalactosaminyltransferase 5 GALNT5 protein |
| Synonyms | |
| Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has activity toward EA2 peptide substrate, but has a weak activity toward Muc2 or Muc1b substrates (By similarity). . |
| Accessions | A5PL16 Q7Z7M9 Q68VJ5 ENST00000259056.5 |
